高脂血症小鼠的动脉粥样硬化消退和胆固醇外排。
Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.
机构信息
Division of Cardiology (T.J., J.L., E.A.F.), Department of Medicine, New York University School of Medicine.
Department of Internal Medicine, MUMC, Maastricht, the Netherlands (T.J., B.A.).
出版信息
Circ Res. 2021 Mar 19;128(6):690-705. doi: 10.1161/CIRCRESAHA.120.317458. Epub 2021 Feb 3.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.高脂血症小鼠的动脉粥样硬化消退和胆固醇外排。
Circ Res. 2021 Mar 19;128(6):690-705. doi: 10.1161/CIRCRESAHA.120.317458. Epub 2021 Feb 3.
2
Is LPL deficiency atherogenic?脂蛋白脂肪酶缺乏会引发动脉粥样硬化吗？
Circ Res. 2008 Jun 6;102(11):e118; author reply e119. doi: 10.1161/CIRCRESAHA.108.173146.
3
Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.通过 ABCA1 转运体增强载脂蛋白 B 代谢障碍 2 型糖尿病患者的胆固醇向高密度脂蛋白的外流。
Metabolism. 2014 May;63(5):727-34. doi: 10.1016/j.metabol.2014.03.001. Epub 2014 Mar 5.
4
9-cis β-Carotene Increased Cholesterol Efflux to HDL in Macrophages.9-顺式β-胡萝卜素增加巨噬细胞中胆固醇向高密度脂蛋白的流出。
Nutrients. 2016 Jul 19;8(7):435. doi: 10.3390/nu8070435.
5
Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.Sortilin 通过溶酶体降解 ABCA1 蛋白促进巨噬细胞胆固醇蓄积和主动脉粥样硬化。
Acta Biochim Biophys Sin (Shanghai). 2019 May 23;51(5):471-483. doi: 10.1093/abbs/gmz029.
6
Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.内皮型脂肪酶在肝中的过表达降低了高密度脂蛋白，但维持了小鼠的胆固醇逆向转运：清道夫受体 B 类 I/ATP 结合盒转运体 A1 依赖性途径的作用。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1454-1467. doi: 10.1161/ATVBAHA.118.311056. Epub 2018 May 10.
7
Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.烟酸或阿昔单抗治疗后高密度脂蛋白的胆固醇外排潜力和抗炎特性。
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1430-8. doi: 10.1161/ATVBAHA.110.207142. Epub 2010 May 6.
8
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.高密度脂蛋白颗粒大小是 ABCA1 介导的巨噬细胞细胞胆固醇流出的关键决定因素。
Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14.
9
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection.体内巨噬细胞特异性逆向胆固醇转运以及抗氧化和抗炎高密度脂蛋白活性测量：预测高密度脂蛋白抗动脉粥样硬化保护作用的新工具。
Atherosclerosis. 2009 Oct;206(2):321-7. doi: 10.1016/j.atherosclerosis.2008.12.044. Epub 2009 Mar 21.
10
A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.一种新型小分子肝 X 受体转录调节剂，那格列酮 B，可抑制载脂蛋白 E 缺陷小鼠的动脉粥样硬化。
Cardiovasc Res. 2016 Oct;112(1):502-14. doi: 10.1093/cvr/cvw183. Epub 2016 Jul 26.
引用本文的文献
1
Hyperchylomicronemia causes endothelial cell inflammation and increases atherosclerosis.高乳糜微粒血症会引发内皮细胞炎症并加剧动脉粥样硬化。
Res Sq. 2024 Nov 25:rs.3.rs-5451391. doi: 10.21203/rs.3.rs-5451391/v1.
2
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.心血管疾病中的巨噬细胞：分子机制与治疗靶点。
Signal Transduct Target Ther. 2024 May 31;9(1):130. doi: 10.1038/s41392-024-01840-1.
3
Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes.载脂蛋白 C3 升高加剧 2 型糖尿病患者的肾脏疾病和相关动脉粥样硬化。
JCI Insight. 2024 May 14;9(12):e177268. doi: 10.1172/jci.insight.177268.
4
β-Carotene accelerates the resolution of atherosclerosis in mice.β-胡萝卜素可加速小鼠动脉粥样硬化的消退。
Elife. 2024 Feb 6;12:RP87430. doi: 10.7554/eLife.87430.
5
The diverse roles of macrophages in metabolic inflammation and its resolution.巨噬细胞在代谢性炎症及其消退中的多种作用。
Front Cell Dev Biol. 2023 Mar 13;11:1147434. doi: 10.3389/fcell.2023.1147434. eCollection 2023.
6
β-carotene accelerates the resolution of atherosclerosis in mice.β-胡萝卜素可加速小鼠动脉粥样硬化的消退。
bioRxiv. 2024 Jan 11:2023.03.07.531563. doi: 10.1101/2023.03.07.531563.
7
Epsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression.埃平纳米治疗通过调节胆固醇转运来增强动脉粥样硬化消退。
Circ Res. 2023 Jan 6;132(1):e22-e42. doi: 10.1161/CIRCRESAHA.122.321723. Epub 2022 Nov 29.
8
The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease.糖尿病相关心血管疾病的残余脂蛋白假说。
Arterioscler Thromb Vasc Biol. 2022 Jul;42(7):819-830. doi: 10.1161/ATVBAHA.122.317163. Epub 2022 May 26.
9
Reducing Endogenous Labile Zn May Help to Reduce Smooth Muscle Cell Injury around Vascular Stents.减少内源性不稳定锌可能有助于减少血管支架周围平滑肌细胞损伤。
Int J Mol Sci. 2022 May 5;23(9):5139. doi: 10.3390/ijms23095139.
10
Macrophages in Atheromatous Plaque Developmental Stages.动脉粥样硬化斑块发育阶段中的巨噬细胞。
Front Cardiovasc Med. 2022 Apr 25;9:865367. doi: 10.3389/fcvm.2022.865367. eCollection 2022.
本文引用的文献
1
Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice.中性粒细胞胞外诱捕网促进糖尿病小鼠巨噬细胞炎症反应并损害动脉粥样硬化消退
JCI Insight. 2020 Apr 9;5(7):134796. doi: 10.1172/jci.insight.134796.
2
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.大颗粒高密度脂蛋白浓度升高及高密度脂蛋白对氧磷酶 1 含量增加与长期 1 型糖尿病患者血管并发症的保护相关。
Diabetes Care. 2020 Jan;43(1):178-186. doi: 10.2337/dc19-0772. Epub 2019 Oct 9.
3
Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.载脂蛋白 AI 通过抑制骨髓生成和斑块炎症促进糖尿病小鼠的动脉粥样硬化消退。
Circulation. 2019 Oct;140(14):1170-1184. doi: 10.1161/CIRCULATIONAHA.119.039476. Epub 2019 Sep 30.
4
Role of LpL (Lipoprotein Lipase) in Macrophage Polarization In Vitro and In Vivo.脂蛋白脂肪酶（LpL）在体外和体内巨噬细胞极化中的作用。
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1967-1985. doi: 10.1161/ATVBAHA.119.312389. Epub 2019 Aug 22.
5
HDL and Reverse Cholesterol Transport.高密度脂蛋白和胆固醇逆向转运。
Circ Res. 2019 May 10;124(10):1505-1518. doi: 10.1161/CIRCRESAHA.119.312617.
6
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.载脂蛋白脂蛋白脂酶基因 Triglyceride-Lowering LPL 变异体与 LDL 受体基因 LDL-C-Lowering LDLR 变异体与冠心病风险的相关性研究。
JAMA. 2019 Jan 29;321(4):364-373. doi: 10.1001/jama.2018.20045.
7
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.从高密度脂蛋白胆固醇到高密度脂蛋白功能：胆固醇流出能力的决定因素。
Curr Opin Lipidol. 2019 Apr;30(2):101-107. doi: 10.1097/MOL.0000000000000589.
8
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.胆固醇质量外排能力、心血管事件的发生与颈动脉斑块的进展。
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):89-96. doi: 10.1161/ATVBAHA.118.311366.
9
Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice.人醛糖还原酶表达可预防糖尿病小鼠动脉粥样硬化消退。
Diabetes. 2018 Sep;67(9):1880-1891. doi: 10.2337/db18-0156. Epub 2018 Jun 11.
10
Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men.性激素对健康男性 HDL 胆固醇外排能力和颗粒浓度具有显著影响。
J Clin Lipidol. 2018 Jul-Aug;12(4):1072-1082. doi: 10.1016/j.jacl.2018.04.013. Epub 2018 Apr 30.
Zotero 插件